Miranda Fox, BS (she/her/hers)

Clinical Trial Manager
Inhibrx, Inc

Miranda Fox is a Clinical Trail Manager with Inhibrx, Inc. Miranda has over fifteen years in the clinical research industry and has worked as a global project lead working across phase I-IV studies in multiple indications. Miranda is based in North Carolina and the current Clinical Trial Manager of the Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109.

Poster(s):

• (P 041) UPDATED EFFICACY AND SAFETY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CHONDROSARCOMA: DATA FROM THE PHASE 1 EXPANSION COHORTS

• (P 317) INBRX-109 IN EWING SARCOMA: PRECLINICAL RATIONALE FOR INITIATION OF A PHASE 1 CHEMOTHERAPY COMBINATION EXPANSION COHORT